Neuro-Oncology

 

Nativis NAT-101 <- click for more information

Basic Eligibility criteria:

  • 18+ years old
  • Subject has historically confirmed diagnosis of GBM
  • Subject has failed or intolerant to radiotherapy and Temozolomide
  • KPS > 60
  • Subject is experiencing first or second recurrence of GBM

NovoCure EF-25 <- click for more information

Basic Eligibility criteria:

  • 18 years of age or older
  • New Diagnosis of brain Metastases from primary or metastatic NSCLC
  • May continue on systemic therapy for NSCLC

Tocagen Tg511-15-01 <- click for more information

Basic Eligibility criteria:

  • reccurent GBM at first or second
  • age 18 to 75
  • at least 4 weeks post last dose of temozolomide

Nativis NAT-109 <- click for more information

Basic Eligibility criteria:

  • at least 18 years of age.
  • There is pathological evidence of GBM
  • Subject received maximal debulking surgery
  • Subject must have at least one measurable lesion per RANO

----------------

If you would like further information about this or any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff at 203.333.1151 and we will be happy to answer any of your questions.